Intuitive Surgical Inc. shares rose in the extended session Thursday after the surgical robot maker topped Wall Street estimates for the quarter and announced Food and Drug Administration clearance for a new product. Intuitive Surgical shares advanced 2.1% to $567. The company reported adjusted fourth-quarter earnings of $5.89 a share on revenue of $676.5 million. Analysts surveyed by FactSet had forecast earnings of $5.04 a share on revenue of $654.7 million. Intuitive Surgical said it received FDA clearance to combine its da Vinci Xi surgical robot with Trumpf Medical’s TruSystem 7000dV operating table to improve adjustments and positioning of the robot during surgery.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News